Skip to main content
Premium Trial:

Request an Annual Quote

All of the Dots

The New York Times profiles Eric Schadt, the chief scientific officer of Pacific Biosciences, from his days in the Air Force to working with his new nonprofit, Sage Bionetworks. In the article Schadt is heralded for his unconventional approach — both to his research and attire. The new venture, Sage, has received data and hardware from Merck's Rosetta subsidiary, where Schadt worked until recently. At Sage, Schadt's colleague, Stephen Friend, will take an open-source approach to studying human biology by bringing together a network of contributors from around the world. "It's all about learning to connect the dots — lots and lots of dots," Schadt says.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.